148 related articles for article (PubMed ID: 24096622)
41. Immunocytochemical colocalization of P16(INK4a) and Ki-67 predicts CIN2/3 and AIS/adenocarcinoma.
Singh M; Mockler D; Akalin A; Burke S; Shroyer A; Shroyer KR
Cancer Cytopathol; 2012 Feb; 120(1):26-34. PubMed ID: 22162342
[TBL] [Abstract][Full Text] [Related]
42. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
[TBL] [Abstract][Full Text] [Related]
43. Correlation of cervical intraepithelial neoplasia with expressions of p16 and Ki67 in exfoliated cervical cells in fluid-based thin-layer samples.
You K; Guo YL; Geng L; Qiao J
Eur J Gynaecol Oncol; 2013; 34(6):535-9. PubMed ID: 24601046
[TBL] [Abstract][Full Text] [Related]
44. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old.
Pirtea L; Secosan C; Margan M; Moleriu L; Balint O; Grigoras D; Sas I; Horhat F; Jianu A; Ilina R
Bosn J Basic Med Sci; 2019 Nov; 19(4):336-341. PubMed ID: 29924960
[TBL] [Abstract][Full Text] [Related]
45. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
[TBL] [Abstract][Full Text] [Related]
46. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
47. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
[TBL] [Abstract][Full Text] [Related]
48. Histologic and immunohistochemical characteristics of neoplastic and nonneoplastic subgroups of atypical squamous lesions of the uterine cervix.
Aoyama C; Liu P; Ostrzega N; Holschneider CH
Am J Clin Pathol; 2005 May; 123(5):699-706. PubMed ID: 15981809
[TBL] [Abstract][Full Text] [Related]
49. Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry.
Stanczuk GA; Baxter GJ; Currie H; Forson W; Lawrence JR; Cuschieri K; Wilson A; Patterson L; Govan L; Black J; Palmer T; Arbyn M
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1629-1635. PubMed ID: 28887297
[No Abstract] [Full Text] [Related]
50. Evaluation of p16/Ki-67 dual-stain cytology performed on self-collected vaginal and clinician-collected cervical specimens for the detection of cervical pre-cancer.
Toliman PJ; Phillips S; de Jong S; O'Neill T; Tan G; Brotherton JML; Saville M; Kaldor JM; Vallely AJ; Tabrizi SN
Clin Microbiol Infect; 2020 Jun; 26(6):748-752. PubMed ID: 31654795
[TBL] [Abstract][Full Text] [Related]
51. P16 immunostaining and HPV testing in histological specimens from the uterine cervix.
Capobianco G; Marras V; Wenger JM; Santeufemia DA; Ambrosini G; Lutzoni R; Dessole M; Cherchi PL
Eur J Gynaecol Oncol; 2013; 34(3):227-30. PubMed ID: 23967551
[TBL] [Abstract][Full Text] [Related]
52. The association between p16 and Ki-67 immunohistostaining and the progression of cervical intraepithelial neoplasia grade 2.
Miyamoto S; Hasegawa J; Morioka M; Hirota Y; Kushima M; Sekizawa A
Int J Gynaecol Obstet; 2016 Jul; 134(1):45-8. PubMed ID: 27233813
[TBL] [Abstract][Full Text] [Related]
53. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T
Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474
[TBL] [Abstract][Full Text] [Related]
54. p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: p16/Ki-67 in cervical papanicolaou Tests.
Atkins K
Cancer Cytopathol; 2011 Jun; 119(3):145-7. PubMed ID: 21442766
[No Abstract] [Full Text] [Related]
55. Immunocytochemical expression of p16INK4A and Ki-67 in cytologically negative and equivocal pap smears positive for oncogenic human papillomavirus.
Longatto Filho A; Utagawa ML; Shirata NK; Pereira SM; Namiyama GM; Kanamura CT; Santos Gda C; de Oliveira MA; Wakamatsu A; Nonogaki S; Roteli-Martins C; di Loreto C; Mattosinho de Castro Ferraz Mda G; Maeda MY; Alves VA; Syrjänen K
Int J Gynecol Pathol; 2005 Apr; 24(2):118-24. PubMed ID: 15782067
[TBL] [Abstract][Full Text] [Related]
56. Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program.
Wentzensen N; Clarke MA; Bremer R; Poitras N; Tokugawa D; Goldhoff PE; Castle PE; Schiffman M; Kingery JD; Grewal KK; Locke A; Kinney W; Lorey TS
JAMA Intern Med; 2019 Jul; 179(7):881-888. PubMed ID: 31081870
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
Yu LL; Chen W; Lei XQ; Qin Y; Wu ZN; Pan QJ; Zhang X; Chang BF; Zhang SK; Guo HQ; Qiao YL
Oncotarget; 2016 Apr; 7(16):21181-9. PubMed ID: 27029033
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of p16, human papillomavirus capsid protein L1 and Ki-67 in cervical intraepithelial lesions: potential utility in diagnosis and prognosis.
Alshenawy HA
Pathol Res Pract; 2014 Dec; 210(12):916-21. PubMed ID: 25149503
[TBL] [Abstract][Full Text] [Related]
59. Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion.
Kuo KT; Chang HC; Hsiao CH; Lin MC
Br J Ophthalmol; 2006 Jul; 90(7):894-9. PubMed ID: 16540490
[TBL] [Abstract][Full Text] [Related]
60. The gastrin-releasing peptide receptor as a marker of dysplastic alterations in cervical epithelial cells.
Cornelio DB; Meurer L; Schwartsmann G; Roesler R
Oncology; 2012; 82(2):90-7. PubMed ID: 22327934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
